AMERICAN CLINICAL LABORATORY ASSN lobbying for AMERICAN CLINICAL LABORATORY ASSN

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Expenses

$660,000.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

LAURA STEVENS KENT

Previously held: Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 11

HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
S 339
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
HR 7118
Genomic Answers for Children’s Health Act of 2026
HR 7148
Consolidated Appropriations Act, 2026
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025
S 1816
Improving Seniors’ Timely Access to Care Act of 2025
S 2355
Patients Deserve Price Tags Act
HR 5582
Patients Deserve Price Tags Act
HR 7961
H–1Bs for Physicians and the Healthcare Workforce Act

Lobbying activity 4

Medical/Disease Research/Clinical Labs

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; diagnostic regulatory reform; artificial intelligence in laboratory services; RESULTS Act (H.R. 5269/S. 2761); Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Act (H.R. 842/S.339); Genomic Answers for Children's Health Act (H.R. 7118); implementation of the Protecting Access to Medicare Act (P.L. 113-93); Consolidated Appropriations Act, 2026 (H.R. 7148).

Medicare/Medicaid

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; program integrity initiatives; RESULTS Act (H.R. 5269/S. 2761); Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Act (H.R. 842/S.339); Genomic Answers for Children's Health Act (H.R. 7118); implementation of the Protecting Access to Medicare Act (P.L. 113-93); Consolidated Appropriations Act, 2026 (H.R. 7148); Improving Seniors' Timely Access to Care Act of 2025 (H.R. 3514/S.1816).

Health Issues

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; diagnostics regulatory reform; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); Consolidated Appropriations Act, 2026 (H.R. 7148); Patients Deserve Price Tags Act (S. 2355/H.R. 5582).

Immigration

H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).